Test Price
2,800 AED✅ Home Collection Available
CPT1B (Carnitine Palmitoyltransferase 1B) Deficiency Genetic Test via Next‑Generation Sequencing (NGS) in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015‑certified NGS with orthogonal Sanger confirmation (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection — available daily from 8 AM to 11 PM across Dubai, Abu Dhabi, and Sharjah.
- Clinical Guidance: Telephonic post‑test review with a DHA‑licensed Consultant Medical Geneticist to interpret results and outline clinical next steps.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731 — most UAE insurers covered.
Test Overview & Methodology
Carnitine palmitoyltransferase 1B (CPT1B) deficiency is a rare autosomal recessive disorder of mitochondrial fatty acid oxidation that can cause severe exercise‑induced rhabdomyolysis and metabolic crises. This comprehensive NGS panel sequences the entire CPT1B gene to detect pathogenic variants with high resolution, enabling early diagnosis, family screening, and personalised management under UAE medical guidelines.
| Feature | Our CPT1B NGS Test | Closest Alternative |
|---|---|---|
| Precision | Full gene coverage (exons + splice sites) with variant allele frequency ≥1% | Single‑variant genotyping (misses rare mutations) |
| Methodology | Next‑Generation Sequencing (NGS) with Sanger confirmation | PCR‑RFLP or targeted mutation panel |
| Turnaround | 3–4 weeks including genetic counselling | 6–8 weeks (send‑out to overseas labs) |
| UAE Compliance | DHA/MOHAP‑standardised report with ICD‑10‑CM & LOINC coding | Variable — often lacks local DHA‑approved nomenclature |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Geneticist, I emphasise that a genetic result must be interpreted in the context of personal and family medical history, biochemical markers, and physical examination. This test reveals susceptibility, not destiny. Never change your lifestyle or medication without a dedicated consultation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠ Important Medication Advisory
Do not discontinue prescribed medication or alter your treatment plan without consulting your ordering physician. Carnitine palmitoyltransferase deficiency requires careful metabolic management; unsupervised changes can trigger rhabdomyolysis and require emergency intervention.
Safety Exclusion Criteria & Red Flags
- Do not collect sample during acute muscle breakdown or severe pain — emergency care precedes genetic testing.
- This test is contraindicated in minors without legal guardian consent per Federal Decree‑Law No. 4 of 2016 on Medical Liability; a court‑appointed guardian’s approval is mandatory.
- If the patient has received a heterologous blood transfusion within the last 120 days, wait at least 4 months to avoid donor DNA interference.
- ER Red Flags: Dark brown urine, severe muscle swelling, extreme fatigue, confusion — seek immediate emergency medical attention.
Patient FAQ & Clinical Guidance
1. What symptoms suggest CPT1B deficiency and warrant this test?
Recurrent episodes of exercise‑induced muscle pain, dark urine after mild exertion, or unexplained rhabdomyolysis in adolescents and adults are hallmark indicators. Genetic testing via this NGS panel confirms the diagnosis and distinguishes CPT1B deficiency from other fatty acid oxidation disorders.
2. How is the sample collected and what is the process?
A certified phlebotomist collects whole blood or a finger‑prick card during a 20‑minute home visit. VIP mobile phlebotomy is available daily from 8 AM to 11 PM. The sample is transported under temperature‑controlled cold chain to our ISO‑accredited laboratory for NGS analysis.
3. Does insurance cover the cost of the CPT1B genetic test?
Most UAE insurance plans cover genetic testing when ordered by a physician for recurrent muscle symptoms. Contact our billing team via WhatsApp at +971 54 548 8731 for direct verification and coverage details specific to your policy.
UAE Regulatory & Data Privacy Adherence
This test is performed under DHA Facility License No. 1143 and adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genomic data is stored securely on UAE servers with explicit patient consent. ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) guarantees quality management across the entire testing workflow.
Clinical & Logistical Metadata
| Test Name | CPT1B (Carnitine Palmitoyltransferase 1B) Deficiency Genetic Test via Next‑Generation Sequencing (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks including genetic counselling |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card Blood Spot |
| Methodology Used | Next‑Generation Sequencing (NGS) with orthogonal Sanger confirmation |
| ICD‑10‑CM Code | E71.314 |
| LOINC Code | 81321-5 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians